-
MEXIDOL® (Emoxipine) 125 mg, 50 coated tablets
$17.00
$22.00 -
ARPEFLU (Umifenovir) 100 mg, 20/30 caps
$24.00 – $33.00
Description
The instruction for medical use of Lantigen medicine B the Trade name Lantigen of B the International unlicensed name Is not present Medicinal a formakapla for intake, 18 ml Structure One ml of drug contain active agents: antigenic extracts: Staphylococcus aureus 79.6 ME, Streptococcus pyogenes (group A) 126.2 ME, Streptococcus pneumoniae (type 3) 63.2 ME, Haemophylus influenzae (type b) 50.22 ME, Branhamella catarrhalis 39.9 ME, Klebsiella pneumoniae 39.8 ME, excipients: polysorbate 80, sodium methylparahydroxybenzoate, chlorhexidin diacetate, water purified. The description Opalescent suspension of gray-brown color Pharmacotherapeutic group Other drugs for treatment of diseases of respiratory organs. The ATX R07AX code the Pharmacological Pharmacokinetics Because of properties of the nature of drug carrying out pharmacokinetic researches is not possible. A pharmacodynamics Lantigen of B is a suspension of the bacterial antigens received in the course of a controlled autolysis of microorganisms which are the most frequent causative agents of respiratory infections (S. pneumoniae, S. pyogenes, B. catarrhalis, S. aureus, H. influenzae, K. pneumoniae). Drug at sublingual introduction causes stimulation of local immune processes thanks to absorption of bacterial antigens through a mucous membrane of a mouth and throat. Lantigen of B acts by stimulation of specific immunity that leads ment of antibodies of a class of secretory immunoglobulins like A (IGA-S) which provide protection against infections, by means of inhibition of adhesion of microorganisms to a mucosal surface of a cover of upper airways. Also Lantigen of B acts as immunoperformance-enhancing drug by means of increase in nonspecific cell-mediated immunity due to increase in proliferation of T-cells, producing IgM, producing IL-1 with monocytes, bactericidal and hemotaksichesky activity of granulocytes. As a result of Lantigen’s use B: – increases the level of development salivary and circulating IgA, IgM, IgG, – the frequency, severity of respiratory infections is reduced – the need for antibacterial therapy Indications by the Adult – for prevention of recurrent respiratory infections, for reduction of frequency, expressiveness of infectious episodes to Children – for prevention of recurrent bacterial upper respiratory tract infections at children with higher cases for the expected age decreases. Drug can reduce the frequency and expressiveness of infectious episodes – in complex use with other drugs at treatment of respiratory infections the Route of administration and doses Children aged from 3 months up to 10 years: one dose which corresponds to the amount of drug received by double pressing the doser (15 drops) under language, once a day (morning), or the half of a dose corresponding to amount of the drug received by single pressing the doser (7-8 drops) twice a day (in the morning and in the evening). To very small children and children who cannot take drug in a mouth, without swallowing, enter during sleep, placing drops between a lower lip and a mandible. Adults and children are more senior than 10 years: one dose which corresponds to the amount of drug received by double pressing the doser (15 drops) under language, twice a day (in the morning and in the evening). Before the use it is necessary to stir up a bottle. Presence (even after stirring) a floating deposit is possible. Each dose needs to be taken in a mouth within 2 minutes, without swallowing to allow suspension better to be dissolved in saliva, and, thus, to facilitate drug absorption. Duration of reception is one bottle (18 ml) for children or two bottles (36 ml) for adults according to the specified dosage. Duration of treatment is 2-3 weeks. Subsequently, the repeated course has to be carried out on 1 bottle for adults or on a half of a bottle for children, according to the specified dosage. Instructions for use Carefully stir up a bottle and break the seal taking a plastic tip which is placed in the middle of a cover, having pulled it and having torn off completely, during turning of a bottle. Uncover, turn a bottle from below up, then clamp the doser between index and a thumb and pressing the doser, receive the necessary quantity of drops. Side effects Seldom (is more rare than 1 on 1000, but is more often than 1 on 10,000 cases of use) temporary undesirable reactions can arise after the first administration of drug. – a rhinorrhea – a constipation, an abdominal pain – temperature increase (≥ 39 °C) without the visible reasons – reactions of hypersensitivity (urticaria, a Quincke’s disease), a bronchospasm – attacks of bronchial asthma and cough of the Contraindication – hypersensitivity to any of drug components – autoimmune diseases – acute intestinal infections – children’s age up to 3 months – pregnancy and the period of a lactation Medicinal interactions are not established. The immune response can be reduced at patients with the congenital or acquired immunodeficiency, at immunosuppressive therapy or at treatment by corticosteroids. The 4 weeks break between intake of any vaccines and B. Lantigen’s use Is recommended to observe special instructions. Administration of drug Lantigen of B has to be stopped in case of fever, especially in an initiation of treatment. Such rare undesirable side effect as temperature increase is possible 39 °C which is not connected with the beginning of an acute respiratory disease are above. In this case treatment has to be stopped and should not be resumed. It is necessary to avoid the accompanying reception of other immunostimulator. The patients having in the anamnesis cases of attacks of bronchial asthma after intake of the medicines containing bacterial extracts should not accept B. Lantigen. In case of hypersensitivity reaction, treatment should stop and be not to resumed immediately. Sodium methylparahydroxybenzoate which is a part of drug can cause allergic reactions (perhaps slowed down type), and in exceptional cases a bronchospasm. Pregnancy and the period of a lactation are Not enough data on Lantigen’s use of B at pregnant women and the feeding women. Drug is contraindicated during pregnancy and a lactation. The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms was not observed impacts of drug on a possibility of driving and other mechanisms. But, it is necessary to consider that special researches were not conducted. Overdose of Cases of overdose it was not observed. A form of release and packing of the Drop for intake. On 18 ml of drug in a glass bottle of the yellow color supplied with the plastic doser, corked by a cover. 1 bottle together with the instruction for medical use in the state and Russian languages is placed in a cardboard box. To Store storage conditions in the dry, protected from light place at a temperature not above 25ºС. To store out of children’s reach! The period of storage Drug cannot be used 3 years after expiry date. Prescription status According to the prescription the Name and the country of the manufacturing organization Bruschettini S.r.l., Italy Via Isonzo 6, 16147 Genova – Italy. Ph.: + 39 010 381 222. Name and country of the owner of the registration certificate of Seltfar SA, Switzerland En Reutet, 1868 Collombey, Switzerland Name and country of the organization packer Bruschettini S.r.l., Italy Via Isonzo 6, 16147 Genova – Italy. Ph.: + 39 010 381 222. The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products and responsible for post-registration observation of safety of medicine: Representative office of Seltfar SA. Almaty, Al-Farabi Ave. 5, Nurla Tau 1A, office 301
Reviews
There are no reviews yet.